Enveric shareholders approve reverse stock split, reject increase in authorized shares

Enveric Biosciences, Inc.

Reverse stock split (1:5 to 1:15) approved: 793,344 for, 190,175 against, 8,309 abstentions.
Authorized share increase to 5B shares rejected: 427,158 for, 555,147 against, 9,523 abstentions.
Six director nominees elected: Michael Webb, George Kegler, Frank Pasqualone, Marcus Schabacker, Joseph Tucker, Sheila DeWitt.
Say-on-pay advisory vote passed: 569,552 for, 26,884 against, 5,297 abstentions.
Ratification of CBIZ CPAs as auditor passed: 960,728 for, 19,347 against, 11,753 abstentions.

item 5.02 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-026364
form_type: 8-K
ticker: ENVB
cik: 0000890821
company_name: Enveric Biosciences, Inc.
filed_at: 2026-05-29T20:13:38+00:00
discovered_at: 2026-05-29T20:15:00.391666+00:00
generated_at: 2026-05-29T20:15:12.984213+00:00
sec_items: ["5.02", "5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-026364
json_url: https://secwatch.observer/filing/0001493152-26-026364.json
markdown_url: https://secwatch.observer/filing/0001493152-26-026364.md
text_url: https://secwatch.observer/filing/0001493152-26-026364.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/890821/000149315226026364/0001493152-26-026364-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/890821/000149315226026364/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

DCOM

Dime Commercial Bancshares name change effective; three executives amend employment agreements

Dime Community Bancshares, Inc. /NY/ June 1, 2026, 4:02 PM ET other_material Items 5.02, 5.03, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BRTX

BRTX shareholders approve 20x increase in authorized shares; CEO/CFO sign 3-year employment agreements

BioRestorative Therapies, Inc. May 29, 2026, 5:07 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DBRG

DigitalBridge shareholders approve 6M share increase to equity plan; 2.36M shares issued for OP unit redemption

DigitalBridge Group, Inc. May 29, 2026, 4:49 PM ET other_material Items 3.02, 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

AIRJ

AirJoule Technologies raises $15M in registered direct offering at $4.10/share

AirJoule Technologies Corp. June 1, 2026, 8:34 AM ET other_material Items 1.01, 5.07, 7.01, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ELOX

Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors

Eloxx Pharmaceuticals, Inc. June 1, 2026, 7:00 AM ET other_material Items 3.02, 3.03, 5.03, 5.02, 9.01

same SEC item: 5.02, 9.01 same event type: other_material similar materiality

Filing page SEC filing

FDXF

FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed

FedEx Freight Holding Company, Inc. June 1, 2026, 6:46 AM ET other_material Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 8.01, 9.01

same SEC item: 5.02, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CRMT

America's Car-Mart forms special committee for strategic alternatives; appoints new independent director

AMERICAS CARMART INC May 29, 2026, 5:30 PM ET other_material Items 1.01, 5.02, 8.01, 9.01

same SEC item: 5.02, 9.01 same event type: other_material similar materiality

Filing page SEC filing

SKYE

Skye Bioscience stockholders approve 3x increase in authorized common shares to 300M

Skye Bioscience, Inc. May 29, 2026, 4:54 PM ET other_material Items 5.03, 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-26-026364

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.